Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cell Cycle

• Publication date

  2012-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.4161/cc.20174PMID 22510564PMCID PMC3372381
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of deubiquitinating enzymes in chromatin regulation

  2011cited by this paper
• An Atlas of Altered Expression of Deubiquitinating Enzymes in Human Cancer

  2011cited by this paper
• The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.

  2011cited by this paper
• α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells.

  2011cited by this paper
• The potential role of ubiquitin c-terminal hydrolases in oncogenesis.

  2010cited by this paper
• Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis.

  2010influential reference
• The therapeutic potential of deubiquitinating enzyme inhibitors.

  2010cited by this paper
• Regulation of transcription factor function by targeted protein degradation: an overview focusing on p53, c-Myc, and c-Jun.

  2010cited by this paper
• The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.

  2010cited by this paper
• Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals

  2010cited by this paper
• DUBs at a glance

  2009cited by this paper
• Suppression of cancer cell growth by promoting cyclin D1 degradation.

  2009cited by this paper
• Curcumin induces stress response, neurite outgrowth and prevent nf-κb activation by inhibiting the proteasome function

  2009cited by this paper
• Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?

  2009cited by this paper
• Defining the human deubiquitinating enzyme interaction landscape.

  2009cited by this paper
• Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells

  2009cited by this paper
• DUBs and cancer: The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors

  2009cited by this paper
• Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53*

  2009cited by this paper
• USP19 Deubiquitinating Enzyme Supports Cell Proliferation by Stabilizing KPC1, a Ubiquitin Ligase for p27Kip1

  2008cited by this paper
• Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo.

  2008cited by this paper
• Natural compounds with proteasome inhibitory activity for cancer prevention and treatment.

  2008cited by this paper
• A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model

  2008cited by this paper
• Dysregulation of the Ubiquitin-Proteasome System by Curcumin Suppresses Coxsackievirus B3 Replication

  2007cited by this paper
• Patented small molecule inhibitors in the ubiquitin proteasome system

  2007cited by this paper
• A Boronic-Chalcone Derivative Exhibits Potent Anticancer Activity through Inhibition of the Proteasome

  2006influential reference
• A genomic and functional inventory of deubiquitinating enzymes.

  2005cited by this paper
• Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition.

  2004cited by this paper
• Imaging 26S proteasome activity and inhibition in living mice

  2003cited by this paper
• Translational Control of Cell Fate: Availability of Phosphorylation Sites on Translational Repressor 4E-BP1 Governs Its Proapoptotic Potency

  2002cited by this paper
• Pharmacophore model for novel inhibitors of ubiquitin isopeptidases that induce p53-independent cell death.

  2002influential reference
• A novel active site‐directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14

  2001cited by this paper
• Cyclopentenone prostaglandins: New insights on biological activities and cellular targets

  2001cited by this paper
• Cyclopentenone Prostaglandins of the J Series Inhibit the Ubiquitin Isopeptidase Activity of the Proteasome Pathway*

  2001influential reference
• A ubiquitin-based tagging system for controlled modulation of protein stability

  2000cited by this paper
• Identification of a 26S proteasome-associated UCH in fission yeast.

  2000cited by this paper
• In vivo disassembly of free polyubiquitin chains by yeast Ubp14 modulates rates of protein degradation by the proteasome

  1997cited by this paper
• The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene

  1993cited by this paper
• Ubiquitin-aldehyde: a general inhibitor of ubiquitin-recycling processes.

  1987cited by this paper

• Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects

  2025cites this paper
• Deubiquitinating enzymes in endometrial cancer and cervical cancer.

  2025cites this paper
• Deciphering USP8’s pivotal role in cancer: mechanisms, clinical insights and contrasts with its function in pituitary adenomas

  2025cites this paper
• Deubiquitinating enzymes in parkinson’s disease: molecular mechanisms and therapeutic potential

  2025cites this paper
• USP5 deubiquitylates and stabilizes FcεRIγ to enhance IgE-induced mast cell activation and allergic inflammation.

  2025cites this paper
• UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progression

  2025cites this paper
• NSC632839 suppresses esophageal squamous cell carcinoma cell proliferation in vitro by triggering spindle assembly checkpoint-mediated mitotic arrest and CREB-Noxa-dependent apoptosis

  2025cites this paper
• Synthesis of USP5-IN-1 derivatives as novel USP5 inhibitors with potent activity against cholangiocarcinoma cells.

  2025cites this paper
• The effect of novel nitrogen-based chalcone analogs on colorectal cancer cells: Insight into the molecular pathways

  2024cites this paper
• (E)-2-Benzylidenecyclanones: Part XX—Reaction of Cyclic Chalcone Analogs with Cellular Thiols: Unexpected Increased Reactivity of 4-Chromanone- Compared to 1-Tetralone Analogs in Thia-Michael Reactions

  2024cites this paper
• DUBs in Alzheimer’s disease: mechanisms and therapeutic implications

  2024cites this paper
• Unraveling the Mechanism of Action of Ubiquitin-Specific Protease 5 and Its Inhibitors in Tumors

  2024cites this paper
• Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease

  2024cites this paper
• Structural basis for the bi-specificity of USP25 and USP28 inhibitors

  2024cites this paper
• Identification and evaluation of antiviral activity of novel compounds targeting SARS-CoV-2 virus by enzymatic and antiviral assays, and computational analysis

  2024cites this paper
• Targeting the deubiquitinase USP2 for malignant tumor therapy (Review)

  2023cites this paper
• USP5: Comprehensive insights into structure, function, biological and disease-related implications, and emerging therapeutic opportunities.

  2023cites this paper
• Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease.

  2023cites this paper
• Functionalized Gold Nanoparticles Suppress the Proliferation of Human Lung Alveolar Adenocarcinoma Cells by Deubiquitinating Enzymes Inhibition

  2023cites this paper
• Endogenous anti-tumorigenic nitro-fatty acids inhibit the ubiquitin-proteasome system by directly targeting the 26S proteasome.

  2023cites this paper
• Ubiquitin receptors play redundant roles in the proteasomal degradation of the p53 repressor MDM2

  2022cites this paper
• Synthesis and biological evaluation of a new chalconate Co (II/III) complex with cytotoxic activity

  2022cites this paper
• Disulfiram and 6-Thioguanine synergistically inhibit the enzymatic activities of USP2 and USP21.

  2021cites this paper
• Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1

  2021cites this paper
• Novel Nitrogen-Based Chalcone Analogs Provoke Substantial Apoptosis in HER2-Positive Human Breast Cancer Cells via JNK and ERK1/ERK2 Signaling Pathways

  2021cites this paper
• Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes

  2021cites this paper
• USP5 Sustains the Proliferation of Glioblastoma Through Stabilization of CyclinD1

  2021cites this paper
• Chalcones as Promising Antitumor Agents by Targeting the p53 Pathway: An Overview and New Insights in Drug-Likeness

  2021cites this paper
• The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression

  2021cites this paper
• Cellular functions regulated by deubiquitinating enzymes in neurodegenerative diseases.

  2021cites this paper
• Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors

  2021cites this paper
• USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes

  2021cites this paper
• Ubiquitin-specific proteases as targets for anticancer drug therapies

  2020cites this paper
• Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines

  2020cites this paper
• Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy

  2020cites this paper
• Drug Development Targeting the Ubiquitin–Proteasome System (UPS) for the Treatment of Human Cancers

  2020cites this paper
• Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics

  2020cites this paper
• Deubiquitinating Enzyme: A Potential Secondary Checkpoint of Cancer Immunity

  2020cites this paper
• Targeting homologous recombination (HR) repair mechanism for cancer treatment: discovery of new potential UCHL-3 inhibitors via virtual screening, molecular dynamics and binding mode analysis

  2020cites this paper
• Chalcone Methoxy Derivatives Exhibit Antiproliferative and Proapoptotic Activity on Canine Lymphoma and Leukemia Cells

  2020cites this paper
• Proteasomal dysfunction and ER stress triggers 2′‐hydroxy‐retrochalcone‐induced paraptosis in cancer cells

  2020cites this paper
• The role of ubiquitin-specific peptidases in cancer progression

  2019cites this paper
• Re-Evaluating the Mechanism of Action of α,β-Unsaturated Carbonyl DUB Inhibitors b-AP15 and VLX1570: A Paradigmatic Example of Unspecific Protein Cross-linking with Michael Acceptor Motif-Containing Drugs

  2019cites this paper
• Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment.

  2019cites this paper
• Halogen Substituents in the Isoquinoline Scaffold Switches the Selectivity of Inhibition between USP2 and USP7

  2018cites this paper
• 6-Thioguanine is a noncompetitive and slow binding inhibitor of human deubiquitinating protease USP2

  2018cites this paper
• Targeting the Ubiquitin Proteasome System in Cancer

  2018cites this paper
• The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity, based on the bis(arylidene)cyclohexanone scaffold

  2018cites this paper
• Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition.

  2018cites this paper
• USP8 Mutations in Pituitary Cushing Adenomas—Targeted Analysis by Next-Generation Sequencing

  2018cites this paper
• Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication

  2017cites this paper
• The roles of ubiquitin modifying enzymes in neoplastic disease.

  2017cites this paper
• Methoxyphenyl chalcone sensitizes aggressive epithelial cancer to cisplatin through apoptosis induction and cancer stem cell eradication

  2017cites this paper
• Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents

  2017cites this paper
• Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges

  2017cites this paper
• The bioefficacy of flavokawain C against colon cancer and the underlying mechanistic insights / Phang Chung Weng

  2017cites this paper
• Cytotoxic effect of helichrysetin on cancer cell lines and its mechanisms / Ho Yen Fong

  2017cites this paper
• Lithocholic Acid Hydroxyamide Destabilizes Cyclin D1 and Induces G0/G1 Arrest by Inhibiting Deubiquitinase USP2a

  2017cites this paper
• Synthesis, Antiproliferative, and Multidrug Resistance Reversal Activities of Heterocyclic α,β‐Unsaturated Carbonyl Compounds

  2016cites this paper
• The Journal of Clinical Investigation

  2016cites this paper
• Dual-labeling of ubiquitin proteins by chemoselective reactions for sensing UCH-L3.

  2016cites this paper
• Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models*

  2016influential citation
• Deubiquitinases and cancer: A snapshot

  2016cites this paper
• Gene Expression Analysis Reveals the Concurrent Activation of Proapoptotic and Antioxidant-Defensive Mechanisms in Flavokawain B–Treated Cervical Cancer HeLa Cells

  2016cites this paper
• The emerging role of deubiquitinating enzymes in genomic integrity, diseases, and therapeutics

  2016cites this paper
• Anti-cancer chalcones: Structural and molecular target perspectives.

  2015cites this paper
• Inhibition of proteasome deubiquitinase activity: a strategy to overcome resistance to conventional proteasome inhibitors?

  2015cites this paper
• Targeting Proteasomal Degradation of Soluble, Misfolded Proteins

  2015cites this paper
• Synthesis and Evaluation of Derivatives of the Proteasome Deubiquitinase Inhibitor b‐AP15

  2015cites this paper
• Deubiquitinase inhibition as a cancer therapeutic strategy.

  2015influential citation
• Effect of bortezomib on migration and invasion in cervical carcinoma HeLa cell.

  2015cites this paper
• Curcusone D, a novel ubiquitin-proteasome pathway inhibitor via ROS-induced DUB inhibition, is synergistic with bortezomib against multiple myeloma cell growth.

  2014cites this paper
• The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer.

  2014cites this paper
• Molecular targeted approaches to cancer therapy and prevention using chalcones.

  2014cites this paper
• Deubiquitinating enzyme inhibitors and their potential in cancer therapy.

  2014cites this paper
• Characterizing substrate selectivity of ubiquitin C-terminal hydrolase-L3 using engineered α-linked ubiquitin substrates.

  2014cites this paper
• Deubiquitinating Enzymes as Novel Targets for Cancer Therapies

  2014cites this paper
• Targeting the ubiquitin proteasome system: beyond proteasome inhibition.

  2013cites this paper
• Deubiquitylating Enzymes and DNA Damage Response Pathways

  2013cites this paper
• Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.

  2013cites this paper
• Erratum to Issaenko OA, et al. Cell Cycle Volume 11, Issue 9; pp. 1804-17.

  2012cites this paper